UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reduction of therapeutic antibody self-association using yeast-display selections and machine learning

mAbs, 2022, Vol.14 (1), p.2146629-2146629

2022

Volltextzugriff (PDF)

Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging

British journal of radiology, 2007-06, Vol.80 (954), p.437-445

2007

Volltextzugriff (PDF)

Symptomatic skeletal event (SSE) dynamics in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223): An interim review of a prospective, non-interventional study (PARABO)

Annals of oncology, 2018-10, Vol.29, p.viii289-viii290

2018

Volltextzugriff (PDF)

On biologically conformal boost dose optimization

Physics in medicine & biology, 2003-01, Vol.48 (2), p.N31-N35

2003

Volltextzugriff (PDF)

FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy

European journal of nuclear medicine and molecular imaging, 2002-06, Vol.29 (6), p.804-808

2002

Volltextzugriff (PDF)

Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

European journal of nuclear medicine and molecular imaging, 2006-03, Vol.33 (3), p.263-269

2006

Volltextzugriff (PDF)

Evaluation of combined transmission and emission tomography for classification of skeletal lesions

American journal of roentgenology (1976), 2004-09, Vol.183 (3), p.655-661

2004

Volltextzugriff (PDF)

Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study

Experimental and clinical endocrinology & diabetes, 2006-05, Vol.114 (5), p.222-226

2006

Volltextzugriff (PDF)

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

The lancet oncology, 2020-04, Vol.21 (4), p.581-592

2020

Volltextzugriff (PDF)

1295P Prospective trial of immuno-(chemo)therapy prior to resection, definitive chemo-radiotherapy, or palliative therapy in patients with borderline resectable or oligometastatic non-small cell lung cancer (KOMPASSneo)

Annals of oncology, 2023-10, Vol.34, p.S747-S747

2023

Volltextzugriff (PDF)

961P Prospective real-world data of immuno(chemo)therapy (IO) prior to resection, definitive chemo-radiotherapy (CRT), or palliative therapy in patients with non-small cell lung cancer (NSCLC) without a primary curative option

Annals of oncology, 2022-09, Vol.33, p.S987

2022

Volltextzugriff (PDF)

119P Prospective trial of immuno-(chemo)therapy (IO) prior to resection, definitive chemo-radiotherapy, or palliative therapy in patients with borderline resectable non-small cell lung cancer (NSCLC) including oligometastatic disease (KOMPASSneo)

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S108

2023

Volltextzugriff (PDF)

80P Prospective analysis of patients with non-small cell lung cancer (NSCLC) receiving neoadjuvant (chemo-) immunotherapy (C-IO) prior to resection or definitive radiochemotherapy (RCT) in routine clinical care (KOMPASS neo)

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S739-S739

2021

Volltextzugriff (PDF)

594P Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational study

Annals of oncology, 2021-09, Vol.32, p.S641-S641

2021

Volltextzugriff (PDF)

860PPain evaluation in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the PARABO observation study

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Pain evaluation in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the PARABO observation study

Annals of oncology, 2019-10, Vol.30, p.v336

2019

Volltextzugriff (PDF)

860P - Pain evaluation in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the PARABO observation study

Annals of oncology, 2019-10, Vol.30, p.v336-v336

2019

Volltextzugriff (PDF)

Influence of PET/CT-introduction on PET scanning frequency and indications. Results of a multicenter study

Nuclear medicine, 2007, Vol.46 (2), p.57-64

2007

Volltextzugriff (PDF)

828PSymptomatic skeletal event (SSE) dynamics in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223): An interim review of a prospective, non-interventional study (PARABO)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Combined transmission and emission tomography in a vastus intermedius muscle stress syndrome

European journal of nuclear medicine and molecular imaging, 2003-04, Vol.30 (4), p.636-636

2003

Volltextzugriff (PDF)

Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors

European journal of nuclear medicine and molecular imaging, 2007-01, Vol.34 (1), p.54-59

2007

Volltextzugriff (PDF)

The Impact of Radiotherapy Protocol Adherence on the Treatment Outcome in Patients With Locally Advanced NSCLC Treated With Concurrent Chemoradiation: Results From the Radiotherapy Quality Assurance of the International Randomized PET-Plan Trial

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.S126-S127

2021

Volltextzugriff (PDF)

Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2007-02, Vol.55 (2), p.165-171

2007

Volltextzugriff (PDF)

Lesion concordance, image quality and artefacts in PET/CT: results of a multicenter study

Nuclear medicine, 2010, Vol.49 (4), p.129-137

2010

Volltextzugriff (PDF)

The Role of Different Chemotherapy Protocols for Concurrent CRT in Locally Advanced NSCLC

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e102-e103

2020

Volltextzugriff (PDF)

1 – 25 von 407

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(320)
Mit Volltextzugriff
(294)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(162)
Life Sciences & Biomedicine
(117)
Humans
(114)
Male
(67)
Female
(64)
Middle Aged
(53)
Adult
(50)
Aged
(42)
Technology
(37)
Radiology, Nuclear Medicine & Medical Imaging
(35)
Biological And Medical Sciences
(34)
Physical Sciences
(29)
Medical Sciences
(28)
Social Sciences
(26)
Sensitivity And Specificity
(21)
Physics
(19)
Reproducibility Of Results
(19)
Oncology
(17)
Positron-Emission Tomography - Methods
(17)
Aged, 80 And Over
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Reduction of therapeutic antibody self-association using yeast-display selections and machine learning

Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging

Symptomatic skeletal event (SSE) dynamics in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223): An interim review of a prospective, non-interventional study (PARABO)

On biologically conformal boost dose optimization

FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy

Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

Evaluation of combined transmission and emission tomography for classification of skeletal lesions

Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

1295P Prospective trial of immuno-(chemo)therapy prior to resection, definitive chemo-radiotherapy, or palliative therapy in patients with borderline resectable or oligometastatic non-small cell lung cancer (KOMPASSneo)

961P Prospective real-world data of immuno(chemo)therapy (IO) prior to resection, definitive chemo-radiotherapy (CRT), or palliative therapy in patients with non-small cell lung cancer (NSCLC) without a primary curative option

119P Prospective trial of immuno-(chemo)therapy (IO) prior to resection, definitive chemo-radiotherapy, or palliative therapy in patients with borderline resectable non-small cell lung cancer (NSCLC) including oligometastatic disease (KOMPASSneo)

80P Prospective analysis of patients with non-small cell lung cancer (NSCLC) receiving neoadjuvant (chemo-) immunotherapy (C-IO) prior to resection or definitive radiochemotherapy (RCT) in routine clinical care (KOMPASS neo)

594P Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational study

860PPain evaluation in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the PARABO observation study

Pain evaluation in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the PARABO observation study

860P - Pain evaluation in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the PARABO observation study

Influence of PET/CT-introduction on PET scanning frequency and indications. Results of a multicenter study

828PSymptomatic skeletal event (SSE) dynamics in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223): An interim review of a prospective, non-interventional study (PARABO)

Combined transmission and emission tomography in a vastus intermedius muscle stress syndrome

Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors

The Impact of Radiotherapy Protocol Adherence on the Treatment Outcome in Patients With Locally Advanced NSCLC Treated With Concurrent Chemoradiation: Results From the Radiotherapy Quality Assurance of the International Randomized PET-Plan Trial

Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer

Lesion concordance, image quality and artefacts in PET/CT: results of a multicenter study

The Role of Different Chemotherapy Protocols for Concurrent CRT in Locally Advanced NSCLC

Suchergebnisse filtern